Time Stamps:

00:00 Introduction to GLP-1 Agonists and Ethical Considerations

03:38 Current Landscape and Insurance Coverage

06:04 Fair Priority Model and Ethical Principles

13:37 Application of Principles and Tiered Allocation

34:30 Challenges and Objections to the Framework

38:41 Future Considerations and Broader Applications



Video version available on YouTube.



In this episode of Medical Ethics, Steve Levine, Dom Sisti, and guest Johan Dellgren explore the challenges surrounding the equitable allocation of GLP-1 receptor agonists (GLP-1 RAs). As these medications gain recognition for their effectiveness in treating obesity and type 2 diabetes, the discussion explores the systemic barriers preventing equal access, including high costs, insurance coverage limitations, and broader health disparities. 



The panel emphasizes the importance of prioritizing those at highest medical risk while also addressing the root causes of healthcare inequities. Watch to learn more about the ethical considerations and potential solutions in ensuring these medications reach those who need them most.